KCA
PRAX icon

KVP Capital Advisors’s Praxis Precision Medicines PRAX Stock Holding History

KVP Capital Advisors’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.4M Hold
42,900
– – 10.54% 1
2026
Q1 		$13.8M Hold
42,900
– – 10.32% 2
2025
Q4 		$12.6M Buy
+42,900
New +$7.99M 12.24% 2

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

KVP Capital Advisors's PRAX Position: Q2 2026 in Review

KVP Capital Advisors held its Praxis Precision Medicines (PRAX) position steady in Q2 2026 at 42,900 shares worth $14.4M. The position accounts for 10.54% of the portfolio, ranked #1.

KVP Capital Advisors first reported a position in PRAX in Q4 2025 and has held it in 3 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • KVP Capital Advisors held 42,900 shares of Praxis Precision Medicines worth $14.4M as of Q2 2026.
  • KVP Capital Advisors left its Praxis Precision Medicines share count unchanged in Q2 2026.
  • Praxis Precision Medicines made up 10.54% of KVP Capital Advisors's portfolio in Q2 2026, its #1 holding.
  • KVP Capital Advisors first reported a position in Praxis Precision Medicines in Q4 2025 and has held it in 3 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on KVP Capital Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.